Timber Creek Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,575
| Closed | -$65.4K | – | 90 |
|
|
2024
Q2 | $65.4K | Hold |
1,575
| – | – | 0.02% | 92 |
|
|
2024
Q1 | $85.4K | Hold |
1,575
| – | – | 0.03% | 90 |
|
|
2023
Q4 | $80.8K | Hold |
1,575
| – | – | 0.03% | 86 |
|
|
2023
Q3 | $91.4K | Hold |
1,575
| – | – | 0.03% | 77 |
|
|
2023
Q2 | $101K | Hold |
1,575
| – | – | 0.03% | 76 |
|
|
2023
Q1 | $109K | Hold |
1,575
| – | – | 0.04% | 73 |
|
|
2022
Q4 | $113K | Hold |
1,575
| – | – | 0.04% | 76 |
|
|
2022
Q3 | $111K | Hold |
1,575
| – | – | 0.04% | 74 |
|
|
2022
Q2 | $121K | Hold |
1,575
| – | – | 0.04% | 74 |
|
|
2022
Q1 | $115K | Hold |
1,575
| – | – | 0.03% | 72 |
|
|
2021
Q4 | $98K | Sell |
1,575
-7,860
| -83% | -$461K | 0.03% | 74 |
|
|
2021
Q3 | $558K | Sell |
9,435
-85
| -0.9% | -$5.6K | 0.18% | 51 |
|
|
2021
Q2 | $636K | Sell |
9,520
-5,275
| -36% | -$344K | 0.21% | 48 |
|
|
2021
Q1 | $934K | Sell |
14,795
-30,360
| -67% | -$1.89M | 0.36% | 43 |
|
|
2020
Q4 | $2.8M | Buy |
45,155
+725
| +2% | +$44.6K | 1.24% | 31 |
|
|
2020
Q3 | $2.68M | Sell |
44,430
-16,290
| -27% | -$980K | 1.47% | 25 |
|
|
2020
Q2 | $3.57M | Buy |
60,720
+385
| +0.6% | +$23K | 2.24% | 18 |
|
|
2020
Q1 | $3.36M | Buy |
60,335
+5,770
| +11% | +$353K | 2.45% | 11 |
|
|
2019
Q4 | $3.5M | Buy |
54,565
+1,585
| +3% | +$90.8K | 2.1% | 18 |
|
|
2019
Q3 | $2.69M | Buy |
52,980
+4,105
| +8% | +$193K | 1.72% | 24 |
|
|
2019
Q2 | $2.22M | Buy |
48,875
+17,630
| +56% | +$821K | 1.43% | 28 |
|
|
2019
Q1 | $1.49M | Buy |
31,245
+1,430
| +5% | +$71.2K | 1.01% | 33 |
|
|
2018
Q4 | $1.55M | Buy |
29,815
+28,190
| +1,735% | +$1.51M | 1.21% | 30 |
|
|
2018
Q3 | $100K | Hold |
1,625
| – | – | 0.06% | 64 |
|
|
2018
Q2 | $89K | Hold |
1,625
| – | – | 0.06% | 65 |
|
|
2018
Q1 | $102K | Hold |
1,625
| – | – | 0.06% | 63 |
|
|
2017
Q4 | $99K | Hold |
1,625
| – | – | 0.06% | 67 |
|
|
2017
Q3 | $103K | Hold |
1,625
| – | – | 0.07% | 69 |
|
|
2017
Q2 | $90K | Hold |
1,625
| – | – | 0.06% | 73 |
|
|
2017
Q1 | $88K | Buy |
1,625
+275
| +20% | +$15.1K | 0.07% | 63 |
|
|
2016
Q4 | $78K | Hold |
1,350
| – | – | 0.06% | 67 |
|
|
2016
Q3 | $72K | Buy |
+1,350
| New | +$86.7K | 0.06% | 70 |
|
Other funds holding BMY
Timber Creek Capital Management's BMY Position: Q3 2024 in Review
Timber Creek Capital Management sold out of Bristol-Myers Squibb (BMY) in Q3 2024, closing a stake of 1,575 shares — an estimated $65.4K sold.
Timber Creek Capital Management first reported a position in BMY in Q3 2016 and held it in 32 quarters. The position peaked at $3.57M in Q2 2020. 2,258 funds tracked by Wall St. Rank hold BMY as of Q3 2024.
- Timber Creek Capital Management reported no remaining Bristol-Myers Squibb position as of Q3 2024 after selling out during the quarter.
- Timber Creek Capital Management sold 1,575 Bristol-Myers Squibb shares in Q3 2024, an estimated $65.4K.
- Timber Creek Capital Management first reported a position in Bristol-Myers Squibb in Q3 2016 and held it in 32 quarters.
- Timber Creek Capital Management's Bristol-Myers Squibb position peaked at $3.57M in Q2 2020.
- 2,258 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2024.
Based on Timber Creek Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.